Literature DB >> 20230580

Histopathologic classification of 171 cases of canine and feline non-Hodgkin lymphoma according to the WHO.

E Vezzali1, A L Parodi, P S Marcato, G Bettini.   

Abstract

A retrospective collection of 171 lymphoid neoplasms (123 dogs and 48 cats) was classified according to the Revised European-American Lymphoma (REAL) classification, adopted in 2002 by the World Health Organization (WHO), to evaluate the WHO system for categorization of canine and feline neoplasms. Microscopic examination was performed after standard hematoxylin-eosin staining and immunohistochemical labelling for B (CD79a) or T (CD3) cell phenotypes. B-cell lymphomas were prevalent in dogs and T-cell lymphomas in cats. B-Large cell lymphoma (B-LCL) frequently showed plasmacytoid differentiation; notably, two canine plasma cell tumours (PCT) expressed both CD79 and CD3. There were difficulties in differentiating B-lymphoblastic lymphoma (B-LBL) from Burkitt-type lymphoma. Furthermore, intestinal T-cell lymphoma (ITCL) exhibited a huge morphologic variability. Finally, multicentric mature small and thymic T-cell lymphomas were diagnosed, although these categories are not codified by the WHO classification.

Entities:  

Mesh:

Year:  2010        PMID: 20230580     DOI: 10.1111/j.1476-5829.2009.00201.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  28 in total

1.  Hemoabdomen secondary to high grade lymphoma.

Authors:  Carolina Azevedo; Stephanie Schleis Lindley; Annette Smith; Kellye Joiner; Peter Christopherson
Journal:  Can Vet J       Date:  2017-07       Impact factor: 1.008

2.  Expression of blood hepatocyte-derived microRNA-122 in canine multicentric lymphoma with hepatic involvement.

Authors:  Eman S Ramadan; Adel Abdelbaset Kubesy; Taher Ahmed Baraka; Faisal Abdelsamad Torad; Shaymaa Ismaiel Salem; Noha Yousef Salem
Journal:  Vet Res Commun       Date:  2019-08-31       Impact factor: 2.459

3.  In situ hybridization of feline leukemia virus in a primary neural B-cell lymphoma.

Authors:  Anna Szilasi; Lilla Dénes; Csaba Jakab; Ildikó Erdélyi; Talita Resende; Fabio Vannucci; Judit Csomor; Míra Mándoki; Gyula Balka
Journal:  J Vet Diagn Invest       Date:  2020-04-10       Impact factor: 1.279

Review 4.  Comparative oncology: what dogs and other species can teach us about humans with cancer.

Authors:  Joshua D Schiffman; Matthew Breen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

Review 5.  Species differences in tumour responses to cancer chemotherapy.

Authors:  Jessica Lawrence; David Cameron; David Argyle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

6.  Affinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma.

Authors:  Allison L Zwingenberger; Michael S Kent; Changying Shi; Sandra L Taylor; Xiucui Chen; Kit S Lam
Journal:  Vet Immunol Immunopathol       Date:  2011-11-25       Impact factor: 2.046

Review 7.  Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?

Authors:  Kristy L Richards; Steven E Suter
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

8.  Lack of Bcl-2 expression in feline follicular lymphomas.

Authors:  Manfred Henrich; Anna Bauknecht; Werner Hecht; Manfred Reinacher
Journal:  J Vet Diagn Invest       Date:  2019-10-04       Impact factor: 1.279

9.  Spontaneous Malignant T Cell Lymphoma in a Young Male Common Marmoset (Callithrix jacchus).

Authors:  Itaru Yamaguchi; Kensuke Myojo; Hiroko Sanada; Eri Sudo; Sayaka Ootsuka; Hiroshi Okumura; Atsuko Takami; Tomomi Yoneshige; Yui Suzuki; Minami Imaizumi; Chie Takada; Naoya Kimoto; Koji Saeki; Katsumi Takaba
Journal:  J Toxicol Pathol       Date:  2013-10-15       Impact factor: 1.628

10.  Large B-cell lymphoma in a dog: A cyto-histopathological evaluation and Immunophenotyping according to WHO classification for canine lymphomas.

Authors:  Zahra Nikousefat; Mohammad Hashemnia; Moosa Javdani
Journal:  Vet Res Forum       Date:  2016-03-15       Impact factor: 1.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.